233 related articles for article (PubMed ID: 12885800)
1. Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group.
Varia MA; Stehman FB; Bundy BN; Benda JA; Clarke-Pearson DL; Alvarez RD; Long HJ;
J Clin Oncol; 2003 Aug; 21(15):2849-55. PubMed ID: 12885800
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal chromic phosphate therapy after second-look laparotomy for ovarian cancer.
Varia M; Rosenman J; Venkatraman S; Askin F; Fowler W; Walton L; Halle J; Currie J
Cancer; 1988 Mar; 61(5):919-27. PubMed ID: 3338057
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin--a gynecologic oncology group study.
Young RC; Brady MF; Nieberg RK; Long HJ; Mayer AR; Lentz SS; Hurteau J; Alberts DS
J Clin Oncol; 2003 Dec; 21(23):4350-5. PubMed ID: 14645424
[TBL] [Abstract][Full Text] [Related]
4. 32P following negative second-look laparotomy for epithelial ovarian cancer.
Rogers L; Varia M; Halle J; Freddo J; Qaqish B; O'Keefe T; Fowler W
Gynecol Oncol; 1993 Aug; 50(2):141-6. PubMed ID: 8375727
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal P-32 is not an effective consolidation therapy after a negative second-look laparotomy for epithelial carcinoma of the ovary.
Peters WA; Smith MR; Cain JM; Lee RB; Yon JL
Gynecol Oncol; 1992 Nov; 47(2):146-9. PubMed ID: 1468691
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant therapy with intraperitoneal chromic phosphate (32P) in women with early ovarian carcinoma after comprehensive surgical staging.
Soper JT; Berchuck A; Dodge R; Clarke-Pearson DL
Obstet Gynecol; 1992 Jun; 79(6):993-7. PubMed ID: 1579329
[TBL] [Abstract][Full Text] [Related]
7. Ovarian carcinoma: adjuvant treatment with P-32.
Reddy S; Sutton GP; Stehman FB; Hornback NB; Ehrlich CE
Radiology; 1987 Oct; 165(1):275-8. PubMed ID: 3628782
[TBL] [Abstract][Full Text] [Related]
8. Phosphorus-32-chromic phosphate for ovarian cancer: I. Fractionated low-dose intraperitoneal treatments in conjunction with platinum analog chemotherapy.
Pattillo RA; Collier BD; Abdel-Dayem H; Ozker K; Wilson C; Ruckert AC; Hamilton K
J Nucl Med; 1995 Jan; 36(1):29-36. PubMed ID: 7799078
[TBL] [Abstract][Full Text] [Related]
9. Use of P-32 in stage III epithelial carcinoma of the ovary.
Spanos WJ; Day T; Jose B; Paris K; Lindberg RD
Gynecol Oncol; 1994 Jul; 54(1):35-9. PubMed ID: 8020836
[TBL] [Abstract][Full Text] [Related]
10. Consolidative 32P after second-look laparotomy for ovarian carcinoma.
Condra KS; Mendenhall WM; Morgan LS; Marcus RB
Radiat Oncol Investig; 1998; 6(2):97-102. PubMed ID: 9572686
[TBL] [Abstract][Full Text] [Related]
11. CA-125 levels after surgical exploration and radioactive chromic phosphate in ovarian cancer patients.
Makhija S; Spanos WJ; Day TG; Doering D
Gynecol Oncol; 1996 Oct; 63(1):85-8. PubMed ID: 8898174
[TBL] [Abstract][Full Text] [Related]
12. Chromic phosphate therapy in carcinoma of the ovary.
Goodman A; Bornstein L; Ball H; Smith DM; Bankoff M
J Am Coll Surg; 1994 Oct; 179(4):401-6. PubMed ID: 7921388
[TBL] [Abstract][Full Text] [Related]
13. Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: a non-randomized comparison using an explanatory analysis: a Gynecologic Oncology Group study.
Greer BE; Bundy BN; Ozols RF; Fowler JM; Clarke-Pearson D; Burger RA; Mannel R; DeGeest K; Hartenbach EM; Baergen RN; Copeland LJ
Gynecol Oncol; 2005 Oct; 99(1):71-9. PubMed ID: 16039699
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant intraperitoneal chromic phosphate therapy for women with apparent early ovarian carcinoma who have not undergone comprehensive surgical staging.
Soper JT; Berchuck A; Clarke-Pearson DL
Cancer; 1991 Aug; 68(4):725-9. PubMed ID: 1855171
[TBL] [Abstract][Full Text] [Related]
15. Pleuroperitoneal migration of intraperitoneal phosphorus-32-chromic phosphate therapy for stage I ovarian carcinoma.
Wilkinson RH
J Nucl Med; 1996 Apr; 37(4):636-9. PubMed ID: 8691256
[TBL] [Abstract][Full Text] [Related]
16. Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy?
Linasmita V; Wilailak S; Thakkinstian A; Srisupundit S; Tangtrakul S; Israngura N; Bullangpoti S
J Med Assoc Thai; 2001 Jul; 84(7):958-65. PubMed ID: 11759976
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal radioactive phosphorus therapy in ovarian carcinoma. Analysis of 313 patients treated primarily or at second-look laparotomy.
Vergote IB; Winderen M; De Vos LN; Tropé CG
Cancer; 1993 Apr; 71(7):2250-60. PubMed ID: 8453546
[TBL] [Abstract][Full Text] [Related]
18. Consolidation intraperitoneal chemotherapy in epithelial ovarian cancer patients following negative second-look laparotomy.
Tarraza HM; Boyce CR; Smith WG; Jones MA
Gynecol Oncol; 1993 Sep; 50(3):287-90. PubMed ID: 8406188
[TBL] [Abstract][Full Text] [Related]
19. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.
Trimbos JB; Parmar M; Vergote I; Guthrie D; Bolis G; Colombo N; Vermorken JB; Torri V; Mangioni C; Pecorelli S; Lissoni A; Swart AM; ;
J Natl Cancer Inst; 2003 Jan; 95(2):105-12. PubMed ID: 12529343
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival with consolidation intraperitoneal chemotherapy for patients with advanced ovarian cancer with pathological complete remission.
Tournigand C; Louvet C; Molitor JL; Fritel X; Dehni N; Sezeur A; Pigné A; Cady J; Milliez J; de Gramont A
Gynecol Oncol; 2003 Nov; 91(2):341-5. PubMed ID: 14599864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
